Home › Companies › IDEAYA BIOSCIENCES INC. › 2024-2025
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and IDEAYA BIOSCIENCES INC.’s Form 8-K, filed June 24, 2025 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of June 24, 2025: 4 items on IDEAYA BIOSCIENCES INC.’s Form 8-K, filed June 24, 2025: 4 passed (calculated).
Significant dissent: 1 director (45.3% against).
Notable dissent: 1 director (10.3% against); 1 say-on-pay vote (77.8% support).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Explore IDEAYA BIOSCIENCES INC. in the interactive database Compare manager voting policies
These tallies are IDEAYA BIOSCIENCES INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 24, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Jeffrey L. Stein, Ph.D. | 69,077,770 | -- | -- | 7,955,948 | 3,030,741 | 90% | Passed (calculated) | — |
| Elect Director: Scott W. Morrison | 42,132,938 | -- | -- | 34,900,780 | 3,030,741 | 54.7% | Passed (calculated) | — |
| 2. The ratification of the selection, by the Audit Committee of the Board of Directors of the Company, of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2025 | 79,645,454 | 228,609 | 190,397 | -- | -- | 99.7% | Passed (calculated) | — |
| 3. Non-binding, advisory vote to approve the compensation of the Company's named executive officers | 59,798,805 | 17,040,207 | 194,706 | -- | 3,030,741 | 78% | Passed (calculated) | — |
Source: IDEAYA BIOSCIENCES INC., Form 8-K, filed with the SEC on June 24, 2025 — read the filing on EDGAR.
See voting trends for Health Care companies, 2024-2025: shareholder support by sector and by company size.
234 asset managers disclosed a vote on at least one IDEAYA BIOSCIENCES INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 4 wordings of this item as funds reported it.
90% Majority: yes · of votes cast
Description as filed by funds: To elect two Class III directors to hold office until the 2028 annual meeting of stockholders or until their successors are elected: Jeffery L. Stein. Ph.D.
IDEAYA BIOSCIENCES INC.’s own tally for this item (“Elect Director: Jeffrey L. Stein, Ph.D.”): 69,077,770 for, 7,955,948 withheld, per its Form 8-K filed June 24, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 90% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 64 asset managers below reported 31,449,325 for, 3,886,787 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 9,391,044 | 0 | 0 | 34,685 | For |
| Vanguard | 4,962,217 | 0 | 0 | 0 | For |
| Federated Hermes | 4,628,526 | 0 | 0 | 0 | For |
| BlackRock | 614,085 | 0 | 0 | 3,378,609 | Mixed |
| Capital Group | 2,844,923 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 2,008,303 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,658,054 | 0 | 0 | 0 | For |
| State Street | 1,489,014 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 771,844 | 0 | 0 | 0 | For |
| Charles Schwab | 717,322 | 0 | 0 | 0 | For |
| Aberdeen | 441,305 | 0 | 0 | 0 | For |
| TIAA | 284,311 | 0 | 0 | 0 | For |
| GENERAL AMERICAN INVESTORS CO INC | 260,261 | 0 | 0 | 0 | For |
| Equitable | 6,083 | 0 | 0 | 234,426 | Withhold |
| Victory Capital | 157,644 | 0 | 0 | 0 | For |
| New York Life | 156,939 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 0 | 148,647 | Withhold |
| Jackson National | 131,090 | 0 | 0 | 534 | For |
| Exchange Place Advisors Trust | 115,150 | 0 | 0 | 0 | For |
| Tema ETF Trust | 65,134 | 0 | 0 | 0 | For |
| Lincoln Financial | 63,900 | 0 | 0 | 359 | For |
| ALPS ETF Trust | 61,002 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 56,544 | 0 | 0 | 0 | For |
| Global X | 52,366 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 46,364 | 0 | 0 | 0 | For |
Showing the 25 largest of 64 asset managers. All 64 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
54.7% Majority: yes · of votes cast
Description as filed by funds: To elect two Class III directors to hold office until the 2028 annual meeting of stockholders or until their successors are elected: Scott W. Morrison
IDEAYA BIOSCIENCES INC.’s own tally for this item (“Elect Director: Scott W. Morrison”): 42,132,938 for, 34,900,780 withheld, per its Form 8-K filed June 24, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 54.7% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 64 asset managers below reported 22,484,073 for, 12,852,039 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 9,283,366 | 0 | 0 | 142,363 | For |
| Vanguard | 4,962,217 | 0 | 0 | 0 | For |
| Federated Hermes | 0 | 0 | 0 | 4,628,526 | Withhold |
| BlackRock | 0 | 0 | 0 | 3,992,694 | Withhold |
| Capital Group | 2,844,923 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 2,008,303 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,658,054 | 0 | 0 | 0 | For |
| State Street | 4,262 | 0 | 0 | 1,484,752 | Withhold |
| MUTUAL FUND SERIES TRUST | 771,844 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 0 | 0 | 717,322 | Withhold |
| Aberdeen | 0 | 0 | 0 | 441,305 | Withhold |
| TIAA | 284,311 | 0 | 0 | 0 | For |
| GENERAL AMERICAN INVESTORS CO INC | 260,261 | 0 | 0 | 0 | For |
| Equitable | 6,083 | 0 | 0 | 234,426 | Withhold |
| Victory Capital | 0 | 0 | 0 | 157,644 | Withhold |
| New York Life | 138,424 | 0 | 0 | 18,515 | Mixed |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 0 | 148,647 | Withhold |
| Jackson National | 131,090 | 0 | 0 | 534 | For |
| Exchange Place Advisors Trust | 0 | 0 | 0 | 115,150 | Withhold |
| Tema ETF Trust | 65,134 | 0 | 0 | 0 | For |
| Lincoln Financial | 0 | 0 | 0 | 64,259 | Withhold |
| ALPS ETF Trust | 0 | 0 | 0 | 61,002 | Withhold |
| MASTER INVESTMENT PORTFOLIO | 0 | 0 | 0 | 56,544 | Withhold |
| Global X | 0 | 0 | 0 | 52,366 | Withhold |
| AIG/SunAmerica | 0 | 0 | 0 | 46,364 | Withhold |
Showing the 25 largest of 64 asset managers. All 64 are in the interactive database (link above).
Combines 11 wordings of this item as funds reported it.
78% Majority: yes · of votes cast
Prior year: 93.2% for (May 31, 2024 meeting) ▼ 15.4 pts
Description as filed by funds: To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement accompanying this Notice of Annual Meeting of Stockholders.
IDEAYA BIOSCIENCES INC.’s own tally for this item (“3. The non-binding, advisory vote to approve the compensation of the Company's named executive officers”): 59,798,805 for, 17,040,207 against, per its Form 8-K filed June 24, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 78% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 9,391,044 | 34,685 | 0 | 0 | For |
| Vanguard | 4,962,217 | 0 | 0 | 0 | For |
| Federated Hermes | 4,628,526 | 0 | 0 | 0 | For |
| BlackRock | 614,085 | 3,378,609 | 0 | 0 | Mixed |
| Capital Group | 0 | 2,844,923 | 0 | 0 | Against |
| JANUS INVESTMENT FUND | 2,008,303 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,658,054 | 0 | 0 | 0 | For |
| State Street | 1,486,715 | 2,299 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 771,844 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 717,322 | 0 | 0 | Against |
| Aberdeen | 441,305 | 0 | 0 | 0 | For |
| TIAA | 284,311 | 0 | 0 | 0 | For |
| GENERAL AMERICAN INVESTORS CO INC | 260,261 | 0 | 0 | 0 | For |
| Equitable | 102,813 | 137,696 | 0 | 0 | Mixed |
| Victory Capital | 157,644 | 0 | 0 | 0 | For |
| New York Life | 138,424 | 18,515 | 0 | 0 | Mixed |
| QUANTITATIVE MASTER SERIES LLC | 0 | 148,647 | 0 | 0 | Against |
| Jackson National | 0 | 131,624 | 0 | 0 | Against |
| Exchange Place Advisors Trust | 0 | 115,150 | 0 | 0 | Against |
| Tema ETF Trust | 65,134 | 0 | 0 | 0 | For |
| Lincoln Financial | 63,900 | 359 | 0 | 0 | For |
| ALPS ETF Trust | 61,002 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 56,544 | 0 | 0 | 0 | For |
| Global X | 0 | 52,366 | 0 | 0 | Against |
| AIG/SunAmerica | 46,364 | 0 | 0 | 0 | For |
Fund voting reports, all 64 managers: 27,609,715 for, 7,706,444 against, 19,953 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 13,129,823 | 0 | 0 | 0 | For |
| Janus Henderson | 5,771,888 | 0 | 0 | 0 | For |
| Federated Hermes | 4,628,526 | 0 | 0 | 0 | For |
| BlackRock | 1,007,275 | 2,974,125 | 0 | 0 | Mixed |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 3,915,311 | 0 | 0 | 0 | For |
| State Street | 3,172,872 | 2,536 | 0 | 0 | For |
| Capital Research Global Investors | 0 | 2,844,923 | 0 | 0 | Against |
| Point72 | 2,593,995 | 0 | 0 | 0 | For |
| Logos Global Management LP | 0 | 2,555,115 | 0 | 0 | Against |
| T. Rowe Price | 2,385,356 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 2,111,522 | 0 | 0 | 0 | For |
| PICTET ASSET MANAGEMENT SA | 1,692,726 | 0 | 0 | 0 | For |
| Sofinnova Investments, Inc. | 1,294,000 | 0 | 0 | 0 | For |
| Fiera Capital Corp | 1,153,211 | 0 | 0 | 0 | For |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 948,694 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 718,378 | 0 | 0 | Against |
| Fisher Asset Management, LLC | 621,615 | 47,804 | 0 | 0 | Mixed |
| DAFNA Capital Management LLC | 651,830 | 0 | 0 | 0 | For |
| Northern Trust | 600,068 | 0 | 0 | 0 | For |
| Redmile Group, LLC | 0 | 490,996 | 0 | 0 | Against |
| Aberdeen | 441,305 | 0 | 0 | 0 | For |
| Citadel | 400,717 | 0 | 0 | 0 | For |
| Avidity Partners Management LP | 0 | 355,000 | 0 | 0 | Against |
| NEW YORK STATE COMMON RETIREMENT FUND | 0 | 326,572 | 0 | 0 | Against |
| AXA INVESTMENT MANAGERS UK Ltd | 0 | 324,020 | 0 | 0 | Against |
Institutional-manager reports, all 191 managers: 50,350,647 for, 12,323,876 against, 2,584 abstained, 1,620 not voted, 164,451 mixed. Showing the 25 largest; every one is in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
99.7% Majority: yes · of votes cast
Prior year: 100.0% for (May 31, 2024 meeting) ▼ 0.3 pts
Description as filed by funds: To ratify the selection, by the Audit Committee of the Company's Board of Directors, of PricewaterhouseCoopers LLP, as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2025;
IDEAYA BIOSCIENCES INC.’s own tally for this item (“2. The ratification of the selection, by the Audit Committee of the Board of Directors of the Company, of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for the year ending”): 79,645,454 for, 228,609 against, per its Form 8-K filed June 24, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.7% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 64 asset managers below reported 35,314,466 for, 1,693 against, 19,953 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 9,425,729 | 0 | 0 | 0 | For |
| Vanguard | 4,962,217 | 0 | 0 | 0 | For |
| Federated Hermes | 4,628,526 | 0 | 0 | 0 | For |
| BlackRock | 3,992,694 | 0 | 0 | 0 | For |
| Capital Group | 2,844,923 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 2,008,303 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,658,054 | 0 | 0 | 0 | For |
| State Street | 1,488,927 | 87 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 771,844 | 0 | 0 | 0 | For |
| Charles Schwab | 717,322 | 0 | 0 | 0 | For |
| Aberdeen | 441,305 | 0 | 0 | 0 | For |
| TIAA | 284,311 | 0 | 0 | 0 | For |
| GENERAL AMERICAN INVESTORS CO INC | 260,261 | 0 | 0 | 0 | For |
| Equitable | 240,509 | 0 | 0 | 0 | For |
| Victory Capital | 157,644 | 0 | 0 | 0 | For |
| New York Life | 156,939 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 148,647 | 0 | 0 | 0 | For |
| Jackson National | 131,624 | 0 | 0 | 0 | For |
| Exchange Place Advisors Trust | 115,150 | 0 | 0 | 0 | For |
| Tema ETF Trust | 65,134 | 0 | 0 | 0 | For |
| Lincoln Financial | 64,259 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 61,002 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 56,544 | 0 | 0 | 0 | For |
| Global X | 52,366 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 46,364 | 0 | 0 | 0 | For |
Showing the 25 largest of 64 asset managers. All 64 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 87,565,252 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 10.76% |
| 2 | Vanguard | 5.67% |
| 3 | Federated Hermes | 5.29% |
| 4 | BlackRock | 4.56% |
| 5 | Capital Group | 3.25% |
| 6 | JANUS INVESTMENT FUND | 2.29% |
| 7 | T. Rowe Price | 1.89% |
| 8 | State Street | 1.70% |
| 9 | MUTUAL FUND SERIES TRUST | 0.88% |
| 10 | Charles Schwab | 0.82% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 14.99% |
| 2 | Janus Henderson | 6.59% |
| 3 | Federated Hermes | 5.29% |
| 4 | BlackRock | 4.55% |
| 5 | DEERFIELD MANAGEMENT COMPANY, L.P. | 4.47% |
| 6 | State Street | 3.63% |
| 7 | Capital Research Global Investors | 3.25% |
| 8 | Point72 | 2.96% |
| 9 | Logos Global Management LP | 2.92% |
| 10 | T. Rowe Price | 2.72% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| FMR (Fidelity) | 13,130,494 | 15.00% | Form 13F, quarter ended March 31, 2025 |
| FMR LLC | 12,635,652 | 14.43% | Proxy statement (DEF 14A), proxy filed April 30, 2025 |
| BlackRock | 9,156,517 | 10.46% | Form 13F, quarter ended March 31, 2025 |
| JANUS HENDERSON GROUP PLC | 7,265,253 | 8.30% | Schedule 13G, filed May 15, 2026 |
| Vanguard Group | 5,092,619 | 5.82% | Form 13F, quarter ended March 31, 2025 |
| T. Rowe Price | 3,475,622 | 3.97% | Form 13F, quarter ended March 31, 2025 |
| State Street | 3,446,230 | 3.94% | Form 13F, quarter ended March 31, 2025 |
| Federated Hermes, Inc. | 3,395,771 | 3.88% | Schedule 13G, filed January 8, 2026 |
| Geode Capital | 2,079,878 | 2.38% | Form 13F, quarter ended March 31, 2025 |
| Point72 Asset Management, L.P. | 1,844,556 | 2.11% | Schedule 13G, filed February 17, 2026 |
Percentages above are of 87,565,252 shares outstanding, as reported by IDEAYA BIOSCIENCES INC. on its Form 10-Q dated March 31, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At IDEAYA BIOSCIENCES INC.'s shareholder meeting held June 24, 2025, in the 2024-2025 proxy season, 234 asset managers reported votes on at least one of its 4 ballot items in their SEC Form N-PX filings, covering 988 separate fund positions. On the most widely held item on that ballot — To approve, on a non-binding, advisory basis, the compensation of the Company's named executive… — FOR was 78% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: IDEAYA BIOSCIENCES INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 24, 2025.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from IDEAYA BIOSCIENCES INC.’s 10-Q dated March 31, 2025. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
IDEAYA BIOSCIENCES INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.
Proxy Votes Now, “IDEAYA BIOSCIENCES (IDYA) 2025 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/ideaya-biosciences-inc/2025 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.